Assets Lave om Dato
Abbott USD 73.35B 440M 2023-06
Acorda Therapeutics USD 364.7M 10.21M 2023-06
Agios Pharmaceuticals USD 937.12M 70.14M 2023-12
Arrowhead Research USD 626.29M 139.27M 2023-12
Enanta Pharmaceuticals USD 462.28M 32.89M 2023-09
Halozyme Therapeutics USD 1.73B 159.39M 2023-12
Heron Therapeutics USD 229.2M 27.98M 2023-09
Insmed USD 1.33B 4.96M 2023-12
Integra LifeSciences USD 3.78B 42.62M 2023-12
Intrexon USD 190.69M 16.84M 2023-09
J&J USD 166.06B 25.62B 2023-09
Ligand Pharmaceuticals USD 787.22M 17.99M 2023-12
Merit Medical Systems USD 2.33B 516.74M 2023-12
Peregrine Pharmaceuticals USD 454.64M 12.3M 2023-09
Rigel Pharmaceuticals USD 115.32M 1.77M 2023-09
Smith & Nephew USD 9.84B 122M 2023-06
Stryker USD 39.88B 1.84B 2023-12
Surmodics USD 185.73M 3.17M 2023-09
Veracyte USD 1.11B 10.04M 2023-12
Xencor USD 952.69M 174.26M 2023-12
Zimmer Biomet Holdings USD 21.5B 279.6M 2023-12



Anika Therapeutics Aktiver - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2024.